Clinical trial for new anti-obesity drug ready to launch at University of Alberta

(University of Alberta Faculty of Medicine & Dentistry) The Alberta Diabetes Institute will host a new clinical trial for an anti-obesity drug targeting people with rare genetic conditions that contribute to their obesity. Led by Andrea Haqq, clinical scientist at the ADI and associate professor in the University of Alberta's Department of Pediatrics, the drug trial will also be tied to a genetic study already underway attempting to create a more comprehensive picture of the genes that are linke...